Luis M. Gonzalez
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of poly(rC)-binding protein 2 (PCBP2) on the malignant phenotype of cholangiocarcinoma.
Journal: Biochemical pharmacology
Published: October 06, 2025
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma.
Journal: Annals of hepatology
Published: July 17, 2025
Factors affecting diabetic patient's long-term quality of life after simultaneous pancreas-kidney transplantation: a single-center analysis.
Journal: Langenbeck's archives of surgery
Published: October 09, 2020
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Journal: Cancers
Published: May 07, 2020
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Journal: Hepatology (Baltimore, Md.)
Published: March 27, 2018
Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy.
Journal: Journal of clinical gastroenterology
Published: January 07, 2017
Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer.
Journal: Medicine
Published: December 05, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026